Category Archive for ‘Uncategorized’

RIMM Bets Pay Off/ Dendreon Over $5

Weekly Market Wrap for 3/29/09

1. Commentary 2. Research In Motion Earnings Preview 3. Further Gains For First Solar? 4. Earnings 5. Current Trades 6. Monday Morning Playbook 7. Closing Thoughts ************************************************** 1. Commentary Despite Friday’s 148 point drubbing, the Dow had a fantastic week as it gained nearly 500 points to finish at 7,776,Read more

More

Why I Love Trading Options

Is Dendreon Headed for Double Digits?

Investing in Biotech stocks can be an exciting, yet risky investment. Investing in Biotech options can takes that same risk/ reward to another level. Assessing how these stocks react to certain news concerning FDA approvals and clinical trials is an art in itself and requires specialized knowledge. However, once youRead more

More

Start Half Positions In Exxon Mobil

The Dow is taking another blow as the index is down 191 points to 6,684. The S&P is off 23 to 689 and well below the 700 level the bulls were clinging to. Things look bad but we have been expecting this bottoming process. I told you the Dow wasRead more

More

Freeport-McMoran Stages Furious Comeback

We were whipsawed out of the Freeport-McMoran (FCX, $32.31, up $3.90) trade from last Friday when the stock dropped $4 yesterday. Naturally, I didn’t expect a 10% drop in the stock price when we bought the March 35 calls (FCXCG, $1.50, up $0.97) for under a $1. The calls tradedRead more

More

Amgen Aching

Amgen (AMGN, $50.08, down $1.15) is no stranger to the blog and we recently closed a trade on some call options back on 2/11. I had profiled the March 60 calls (YAACL, $0.07, down $0.09) back on 2/2 and at the time they were going for $1.20. Amgen went onRead more

More

Trade Updates: AZO, BAC, IBM, SWY

Not much has been happening with AutoZone (AZO, $141.08, down $2.80) since I profiled the stock on Tuesday. The March 160 calls (AZOCL, $1.50, down $1.50) were at $2.30 and the March 130 puts (AZOOF, $3.80, down $0.80) were at $3.90. My initial hopes were that the stock would haveRead more

More

Dow Falls Below 7500

Research in Motion (RIMM, $41.87, down $0.23) is trading lower again this morning and has hit a low of $40.97. I had mentioned yesterday that the stock looks headed below $40 but sometimes its nerve racking when you have a short position in a well-known and popular stock that isRead more

More

Night Owls Calling

Just checking in on the futures…I must be sleepwalking. At 1AM right coast time, the Dow futures are up 54, the S&P 500 is up 6.30 while the Nasdaq futures are up 5.50. This is indicating a slightly higher open to start Wednesday’s trading session but European markets have yetRead more

More

CFTC Disclosure:

GOVERNMENT REGULATIONS REQUIRE DISCLOSURE OF THE FACT THAT WHILE THESE METHODS MAY HAVE WORKED IN THE PAST, PAST PERFORMANCE IS NOT NECESSARILY INDICATIVE OF FUTURE PERFORMANCE. WHILE THERE IS A POTENTIAL FOR PROFITS THERE IS ALSO A RISK OF LOSS. A LOSS INCURRED IN CONNECTION WITH Momentum Options Trading, LLC CAN BE SIGNIFICANT. YOU SHOULD THEREFORE CAREFULLY CONSIDER WHETHER TRADING IS SUITABLE FOR YOU IN LIGHT OF YOUR FINANCIAL CIRCUMSTANCE. THERE IS SUBSTANTIAL RISK IN TRADING. A LOSS INCURRED IN CONNECTION WITH FUTURES TRADING CAN BE SIGNIFICANT. WE MAKE NO CLAIM REGARDING PAST OR FUTURE PERFORMANCE. WE MERELY TRACK EVERY TRADE AND SHOW THE PERFORMANCE OF ALL TRADES THE SYSTEM OR NEWSLETTER PRODUCES. SIMULATED TRADING IS DIFFERENT THAN TRADING REAL MONEY. HYPOTHETICAL RESULTS ARE NOT REAL RESULTS. PLEASE CONTACT YOUR BROKER ABOUT THE RISK OR TRADING STOCKS, OPTIONS OR FUTURES. ALL COMMUNICATIONS ARE OPINIONS NOT ADVICE.

CFTC RULE 4.41 – HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.